Internet
3D Printed Drugs Market to Reach US$ 2,064.8 Million by 2027 Globally | CAGR: 15.2% | UnivDatos Market Insights
The proliferating prevalence of chronic disease coupled with the surging number of patients with dysphagia across the globe is leading to the growing demand for instantaneous soluble drugs therefore the market of 3D printed is witnessing an uptick. In a report, Also, a surge in the geriatric population is demanding soluble and personalized drugs. Many older people will have swallowing problems. The prevalence of dysphagia increases with the degree of frailty present and the degree of dependence irrespective of ethnicity. Furthermore, technological advancements in healthcare owing to the rapidly increasing demand for medicines coupled with the government's emphasis and investments in the 3D printing industry is also contributing to the growth of the market.
https://univdatos.com/report/global-3d-printed-drugs-market-current-analysis-and-forecast-2020-2027
The COVID 19 pandemic has busted out as the demand for medicines, medical equipment, and devices therefore, the adoption of 3D printing has witnessed an uptick. 3D printing is a faster manufacturing technique because of its digital manufacturing capabilities. The companies in the additive manufacturing industry have launched several printers to boost the production of medicines and other required products. Moreover, the drug shortage during the COVID pandemic has gain pharma manufacturers' interest in the quick delivery of medicines. When considering the effect of the second wave of COVID-19 cases medication shortages will likely continue to escalate.
https://univdatos.com/report/global-3d-printed-drugs-market-current-analysis-and-forecast-2020-2027
Global 3D Printed Drugs Market report is studied thoroughly with several aspects that would help stakeholders in making their decisions more curated.
The inkjet printing segment dominated the technology segment of the 3D printed drugs market in 2019 and will grow at 16.63% CAGR to reach US$ 954.1 million by the year 2027.
Amongst applications, the neurology segment accounted for the largest share and is expected to grow at 16.25% CAGR during the forecast period 2021-2027. In 2019, the neurology 3D printed drugs segment accounted for a revenue share of almost 35.1%.
Amongst drug form, tablet form accounted for the largest share and is expected to grow at 16.3% CAGR during the forecast period 2021-2027. In 2019, the tablet drugs segment accounted for a revenue share of almost 29.8%.
Amongst drugs, Spritam being the FDA-approved first 3D printed drug grabbed the largest share and accounted for 65.2% in 2019. However, other drugs are expected to grow at the highest CAGR during the forecast period.
In 2019, the research laboratories segment dominated the global 3D Printed Drugs market with nearly 51.7% of the market share and it is anticipated by 2027, the segment will garner US$ 1,078.2 million of the market.
Based on the estimation, the North America region dominated the 3D Printed Drugs market with almost US$ 306.8 million revenue in 2019. At the same time, the Asia-Pacific region is expected to grow remarkably with a CAGR of 19.8% over the forecast period owing to the surging government's emphasis on 3D printing in the healthcare industry.
https://univdatos.com/report/global-3d-printed-drugs-market-current-analysis-and-forecast-2020-2027
The degree of competition among prominent global companies has been elaborated by analyzing several leading key players operating worldwide. The specialist team of research analysts sheds light on various traits such as global market competition, market share, most recent industry advancements, innovative product launches, partnerships, mergers, or acquisitions by leading companies in the 3D printed drugs market. The leading players have been analyzed by using research methodologies for getting insight views on global competition.
We understand the requirement of different businesses, regions, and countries, we offer customized reports as per your requirements of business nature and geography. Please let us know If you have any custom needs.
https://univdatos.com/report/global-3d-printed-drugs-market-current-analysis-and-forecast-2020-2027
Contact:
UnivDatos Market Insights Pvt. Ltd.
4th & 5th Floor,
C-80B, Sector 8, Noida,
Pin code- 201301, UP, India
Ph: +91-7838604911
Email: sales@univdatos.com
Logo: https://mma.prnewswire.com/media/1225049/UnivDatos_Logo.jpg